WallStreetZenWallStreetZen

NASDAQ: HOWL
Werewolf Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their HOWL stock forecasts and price targets.

Forecast return on equity

Is HOWL forecast to generate an efficient return?

Company
-304.27%
Industry
21.05%
Market
175.22%
HOWL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HOWL forecast to generate an efficient return on assets?

Company
-205.22%
Industry
22.87%
HOWL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HOWL earnings per share forecast

What is HOWL's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.91
Avg 2 year Forecast
-$0.60
Avg 3 year Forecast
-$0.91

HOWL revenue forecast

What is HOWL's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%
HOWL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HOWL revenue growth forecast

How is HOWL forecast to perform vs Biotechnology companies and vs the US market?

Company
-100%
Industry
31.15%
Market
12.98%
HOWL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HOWL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HOWL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HOWL$1.10N/AN/A
YARW$20.00$58.00+190.00%Strong Buy
ELOX$13.20$37.50+184.09%Strong Buy
PLRX$0.86N/AN/A
CNTB$0.84$5.43+550.18%Strong Buy
View Top Biotech Stocks

Werewolf Therapeutics Stock Forecast FAQ

What is HOWL's earnings growth forecast for 2026-2028?

(NASDAQ: HOWL) Werewolf Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.56%.

Werewolf Therapeutics's earnings in 2026 is -$34,613,000.On average, 4 Wall Street analysts forecast HOWL's earnings for 2026 to be -$44,118,232, with the lowest HOWL earnings forecast at -$42,388,105, and the highest HOWL earnings forecast at -$45,415,827. On average, 3 Wall Street analysts forecast HOWL's earnings for 2027 to be -$29,246,918, with the lowest HOWL earnings forecast at -$28,099,980, and the highest HOWL earnings forecast at -$30,107,121.

In 2028, HOWL is forecast to generate -$44,118,232 in earnings, with the lowest earnings forecast at -$42,388,105 and the highest earnings forecast at -$45,415,827.

If you're new to stock investing, here's how to buy Werewolf Therapeutics stock.

What is HOWL's revenue growth forecast for 2026-2028?

(NASDAQ: HOWL) Werewolf Therapeutics's forecast annual revenue growth rate of -100% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.98%.

Werewolf Therapeutics's revenue in 2026 is $21,000,000.On average, 3 Wall Street analysts forecast HOWL's revenue for 2026 to be $0, with the lowest HOWL revenue forecast at $0, and the highest HOWL revenue forecast at $0. On average, 3 Wall Street analysts forecast HOWL's revenue for 2027 to be $0, with the lowest HOWL revenue forecast at $0, and the highest HOWL revenue forecast at $0.

In 2028, HOWL is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is HOWL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: HOWL) forecast ROA is -205.22%, which is lower than the forecast US Biotechnology industry average of 22.87%.

What is HOWL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: HOWL) Werewolf Therapeutics's current Earnings Per Share (EPS) is -$0.72. On average, analysts forecast that HOWL's EPS will be -$0.91 for 2026, with the lowest EPS forecast at -$0.87, and the highest EPS forecast at -$0.93. On average, analysts forecast that HOWL's EPS will be -$0.60 for 2027, with the lowest EPS forecast at -$0.58, and the highest EPS forecast at -$0.62. In 2028, HOWL's EPS is forecast to hit -$0.91 (min: -$0.87, max: -$0.93).

What is HOWL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: HOWL) forecast ROE is -304.27%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.